The maker of electrocardiographic mapping technology, backed by Japan-based distributor of cardiovascular devices DVX, appoints Bullock to role a month after a $7.5m funding round, as executive chairman Steve Arless leaves.
CardioInsight Technologies, a US-based healthcare company previously backed by Japan-based distributor of cardiovascular devices DVX, has appointed Jim Bullock as its chairman.
The company raised $7.6m from undisclosed investors last month.
Bullock was chief executive of Atritech, an electrophysiology company bought by Boston Scientific in 2011, and Endocardial Solutions, a catheter-based cardiac mapping company bought by St. Jude Medical in 2005.
CardioInsight added Steve Arless would step down Chairman and Chief Executive Officer. The company added Charu Ramanathan, co-founder and…
